AR and neoplasm: These studies again revealed significantly inhibited tumor growth in both Ad-AR and Ad-AR-V7 treated groups compared to those receiving Ad-Control vaccines (Figure 2f), resulting in an overall median survival benefit for Ad-AR and Ad-AR-V7-vaccinated groups (Figure 2g).